Approval push by BridgeBio after dwarfism drug boosts the height of children in phase 3

February 17, 2026

Japan’s MHLW approves AstraZeneca and Moderna Covid-19 vaccines

May 28, 2021

Novo’s Wegovy Successful in Reducing Risk of Cardiovascular Events in Phase 3 Trial

August 8, 2023

Must Read

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

July 20, 2026

The Return of M&A as a Growth Strategy in Biopharma

July 20, 2026

Top 10 Reasons Pharma Companies Are Building Internal AI Governance Teams

July 20, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

Axiom Reports Phase 1 Results for Stem Cell Therapy in Newborn Brain Injuries

Sac-TMT and Keytruda Improve Progression-Free Survival in PD-L1-Negative NSCLC

Veradermics Reports Phase 2 Results for VDPHL01 in Women With Pattern Hair Loss

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

AstraZeneca travels to China once more and purchases Dizal’s lung cancer medication for up to $1.5 billion

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

The Return of M&A as a Growth Strategy in Biopharma

Top 10 Reasons Pharma Companies Are Building Internal AI Governance Teams

Why Traditional Pharma Marketing Models Are Being Rewritten

The Future of Smart Biopharmaceutical Manufacturing

Regulatory

Battery and Shutdown Issues Lead to Another Class 1 Warning for Getinge’s Heart Pump

Editor Picks

Approval push by BridgeBio after dwarfism drug boosts the height of children in phase 3

Japan’s MHLW approves AstraZeneca and Moderna Covid-19 vaccines

Novo’s Wegovy Successful in Reducing Risk of Cardiovascular Events in Phase 3 Trial

Must Read

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

The Return of M&A as a Growth Strategy in Biopharma

Top 10 Reasons Pharma Companies Are Building Internal AI Governance Teams

Hot Topics

About Us

Follow Us